Munich - Delayed Quote EUR

Embecta Corp (JX7.MU)

10.90

0.00

(0.00%)

As of 8:01:35 AM GMT+2. Market Open.

Embecta to host Analyst and Investor Day on May 22, 2025

PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on May 22, 2025, from 9:00 a.m. to 12:30 p.m. in New York City. Dev Kurdikar, President & Chief Executive Officer, and Jake Elguicze, Chief Financial Officer, will be joined by members of the embecta leadership team to present strategic and business overview, including value creation opportu

GlobeNewswire 4 days ago

EMBC
Beyond the drug: Closing the knowledge gap for injectable diabetes meds

As the diabetes and weight loss market booms, more collaboration between pharma and medtech could help patients get the most out of injectable drugs.

Pharma Voice 10 days ago

EMBC
embecta to Report Fiscal Second Quarter 2025 Financial Results

PARSIPPANY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal second quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, May 9, 2025. Those who would like to participate may access the live webcast here, or access the teleconference here. The live w

GlobeNewswire 10 days ago

EMBC
Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

First Update in Nearly 10 Years by FITTER Forward Initiative Sets Out to Transform Insulin Injection Technique EducationPARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new landmark publication in the Mayo Clinic Proceedings. The publication introduces the FITTER Forward Expert Recommendations, an updated set of global best practices for insulin injection tec

GlobeNewswire last month

EMBC
Undervalued Small Caps With Insider Action Across Regions In April 2025

Over the last 7 days, the United States market has experienced a 3.4% decline, although it has risen by 6.1% over the past year with earnings projected to grow by 14% annually. In this environment, identifying small-cap stocks that are perceived as undervalued and have notable insider activity can present intriguing opportunities for investors seeking to capitalize on potential growth within diverse regions.

Simply Wall St. last month

MPB

EMBC

WTBA
Are Investors Undervaluing Embecta Corp. (NASDAQ:EMBC) By 49%?

Key Insights Embecta's estimated fair value is US$24.36 based on 2 Stage Free Cash Flow to Equity Embecta's US$12.43...

Simply Wall St. last month

EMBC
Embecta Insider Ups Holding By 20% During Year

Viewing insider transactions for Embecta Corp.'s ( NASDAQ:EMBC ) over the last year, we see that insiders were net...

Simply Wall St. 2 months ago

EMBC
Embecta Corp. (EMBC): Among Last Week’s Worst Dividend Stocks

We recently published a list of These Were Last Week’s 10 Worst Dividend Stocks. In this article, we are going to take a look at where Embecta Corp. (NASDAQ:EMBC) stands against other last week’s worst dividend stocks. Dividend stocks have historically been the top preference for many investors seeking stable income. However, as the years […]

Insider Monkey 2 months ago

EMBC
embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that Jake Elguicze, embecta’s Chief Financial Officer, will present at the J.P. Morgan Global Leveraged Finance Conference in Miami on Tuesday, February 25, 2025 at 3:00 p.m. ET. About embectaembecta is a global diabetes care company that is leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partner

GlobeNewswire 2 months ago

EMBC
Embecta Corp (EMBC) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ...

Embecta Corp (EMBC) reports a mixed quarter with revenue declines but strong growth in safety products and contract manufacturing, while focusing on debt reduction and strategic partnerships.

GuruFocus.com 2 months ago

EMBC
Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates

Embecta Corp. (EMBC) delivered earnings and revenue surprises of 44.44% and 2.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

SHC

EMBC
Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results

PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month period ended December 31, 2024. "Building on our momentum from 2024, embecta began the year with solid performance," said Devdatt (Dev) Kurdikar, Chief Executive Officer of embecta. "We remain on track to complete the restructuring plan associated with the discontinuation of the insulin patch pump progr

GlobeNewswire 2 months ago

EMBC
embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on March 14, 2025 to stockholders of record at the close of business on February 28, 2025. About embectaembecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to

GlobeNewswire 2 months ago

EMBC
embecta to Report Fiscal First Quarter 2025 Financial Results

PARSIPPANY, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal first quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Thursday, February 6, 2025. Those who would like to participate may access the live webcast here, or access the teleconference here. The l

GlobeNewswire 3 months ago

EMBC
The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC

Doximity, Omnicell, Embecta, Cencora and EDOC are included in this Analyst Blog.

Zacks 3 months ago

EMBC

OMCL

DOCS
4 MedTech Stocks Poised to Thrive Under Second Trump Presidency

Four MedTech stocks that are set to benefit from Trump 2.0 are DOCS, OMCL, EMBC and COR.

Zacks 3 months ago

OMCL

EMBC

DOCS
The Zacks Analyst Blog Highlights Doximity, BrightSpring Health Services and Embecta

Doximity, BrightSpring Health Services and Embecta are part of the Zacks top Analyst Blog.

Zacks 3 months ago

BTSG

^GSPC

EMBC
3 Stocks Trading Near 52-Week High With Room to Rise Further

Investors target stocks that have been on a bullish run lately. Stocks like EMBC, NFG and REVG are seeing price strength and the momentum is likely to continue.

Zacks 3 months ago

REVG

EMBC

NFG
3 Medical Services Stocks to Buy to Counter Labor Shortage Woes

The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. DOCS, BTSG and EMBC are set to gain the most. However, healthcare staffing shortage is leading to an increase in labor wages.

Zacks 3 months ago

^GSPC

BTSG

DOCS
Zacks.com featured highlights include The Gap, Embecta, Blue Bird and ZIM Integrated Shipping Services

The Gap, Embecta, Blue Bird and ZIM Integrated Shipping Services are part of the Zacks Screen of the Week article.

Zacks 4 months ago

BLBD

EMBC

Performance Overview

Return	JX7.MU	S&P 500 (^GSPC)
YTD	-44.87%	-3.64%
1-Year	+19.17%	+11.91%
3-Year	-64.14%	+36.39%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Embecta Corp (JX7.MU)

Embecta to host Analyst and Investor Day on May 22, 2025

Beyond the drug: Closing the knowledge gap for injectable diabetes meds

embecta to Report Fiscal Second Quarter 2025 Financial Results

Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

Undervalued Small Caps With Insider Action Across Regions In April 2025

Are Investors Undervaluing Embecta Corp. (NASDAQ:EMBC) By 49%?

Embecta Insider Ups Holding By 20% During Year

Embecta Corp. (EMBC): Among Last Week’s Worst Dividend Stocks

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

Embecta Corp (EMBC) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ...

Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates

Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results

embecta Announces Quarterly Cash Dividend

embecta to Report Fiscal First Quarter 2025 Financial Results

The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC

4 MedTech Stocks Poised to Thrive Under Second Trump Presidency

The Zacks Analyst Blog Highlights Doximity, BrightSpring Health Services and Embecta

3 Stocks Trading Near 52-Week High With Room to Rise Further

3 Medical Services Stocks to Buy to Counter Labor Shortage Woes

Zacks.com featured highlights include The Gap, Embecta, Blue Bird and ZIM Integrated Shipping Services

Performance Overview